From fly wings to targeted cancer therapies: a centennial for notch signaling.

Cancer Cell 2014 Mar;25(3):318-34

Howard Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, NY 10016, USA; NYU Cancer Institute and Helen L. and Martin S. Kimmel Center for Stem Cell Biology, NYU School of Medicine, New York, NY 10016, USA. Electronic address:

Since Notch phenotypes in Drosophila melanogaster were first identified 100 years ago, Notch signaling has been extensively characterized as a regulator of cell-fate decisions in a variety of organisms and tissues. However, in the past 20 years, accumulating evidence has linked alterations in the Notch pathway to tumorigenesis. In this review, we discuss the protumorigenic and tumor-suppressive functions of Notch signaling, and dissect the molecular mechanisms that underlie these functions in hematopoietic cancers and solid tumors. Finally, we link these mechanisms and observations to possible therapeutic strategies targeting the Notch pathway in human cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.02.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040351PMC
March 2014
5 Reads

Publication Analysis

Top Keywords

notch signaling
12
notch pathway
8
notch
6
discuss protumorigenic
4
review discuss
4
decisions variety
4
protumorigenic tumor-suppressive
4
tumor-suppressive functions
4
signaling dissect
4
functions notch
4
tumorigenesis review
4
pathway tumorigenesis
4
accumulating evidence
4
years accumulating
4
tissues years
4
linked alterations
4
alterations notch
4
variety organisms
4
dissect molecular
4
organisms tissues
4

Altmetric Statistics

Similar Publications